EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities

Hocine Sadam Nesrat, Abdelatif Aouadi iD, Ibtissam Laib iD, Salah Eddine Laouini iD, Abderrhmane Bouafia iD, Djamila Hamada Saoud iD, Halima Zidane, Hafidha Terea, Mahmood M S Abdullah iD, Tomasz Trzepieciński iD, Dalila Saidane-Mosbahi

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hocine Sadam Nesrat und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analysis, Treatment and Recovery of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunis…. Hauptthemen laut MEDLINE: Copper, Zinc Oxide, Antioxidants, Hypoglycemic Agents. Die Arbeit nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Algerian Directorate General for Scientific Research and Technological Development-DGRSDT and El-Oued University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A ZnO/CuO@amoxicillin nanocomposite was synthesized via a sol–gel route and characterized as a biphasic wurtzite ZnO–monoclinic CuO system with crystallite sizes of about 10–12 nm and an optical band gap of 3.30–3.36 eV, indicating defect‐rich interfaces favorable for redox activity. In antidiabetic assays, the nanocomposite showed strong inhibitory effects on alpha‐amylase (IC 50 = 21.57 ± 1.68 mg/mL) and alpha‐glucosidase (IC 50 = 13.95 ± 0.76 mg/mL), with activities comparable to acarbose, while anti‐inflammatory tests yielded low IC 50 values of 0.22 ± 0.03 mg/mL for egg albumin denaturation and 0.34 ± 0.07 mg/mL for human serum albumin, approaching the performance of diclofenac. Antioxidant performance was outstanding, with total antioxidant capacity of 298.27 ± 4.70 mg ascorbic acid equivalents per gram and ferric reducing antioxidant power of 311.67 ± 2.53 mM Fe 2 + /g, both higher than ascorbic acid, alongside efficient hydrogen peroxide scavenging (IC 50 = 0.16 ± 0.04 mg/mL) and protection against H 2 O 2 /FeCl 3 ‐induced hemolysis at an IC 50 of 0.007 ± 0.00 mg/mL; together with moderate but significant acetylcholinesterase inhibition (IC 50 = 33.16 ± 3.02 mg/mL vs. 21.80 ± 2.74 mg/mL for donepezil), these results support ZnO/CuO@amoxicillin as a multifunctional nano‐platform for managing oxidative stress, inflammation, and metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperZinc OxideAntioxidantsHypoglycemic AgentsCholinesterase InhibitorsNanocompositesAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory AgentsHumansAcetylcholinesteraseAnimalsalpha-Amylasesalpha-Glucosidases

Stichwörter der Autor:innen

ZnO/CuO nanocompositeamoxicillin functionalizationantidiabeticantioxidant activityanti‐inflammatoryneuroprotective

Substanzen

CopperZinc OxideAntioxidantsHypoglycemic AgentsCholinesterase InhibitorsAcetylcholinesterasealpha-Amylasesalpha-GlucosidasesAnti-Inflammatory Agents, Non-Steroidalcupric oxide

Autor:innen und Institutionen

  • Laboratory of Analysis, Treatment and Recovery of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
  • Laboratory of Biotechnology Biomaterials and Condensed Matter (LBBCM), Faculty of Technology, University of El Oued, El Oued, Algeria.
  • Process Engineering Laboratory, Applied Sciences Faculty, Kasdi Merbah University, Ouargla, Algeria.
  • Faculty of Biology, Department of Cellular and Molecular Biology, University of El Oued, El Oued, Algeria.
  • Laboratory of Biodiversity and Application of Biotechnology in the Agricultural Field, Faculty of Natural and Life Sciences, University of El Oued, El Oued, Algeria.
  • Department of Process Engineering and Petrochemistry, Faculty of Technology, University of El Oued, El Oued, Algeria.

ORCID-Profile: Abdelatif Aouadi, Ibtissam Laib, Salah Eddine Laouini, Abderrhmane Bouafia, Djamila Hamada Saoud, Mahmood M S Abdullah, Tomasz Trzepieciński

Förderung

  • Algerian Directorate General for Scientific Research and Technological Development-DGRSDT and El-Oued University

Zitieren

APA

Nesrat, H. S., Aouadi, A., Laib, I., Laouini, S. E., Bouafia, A., Saoud, D. H., Zidane, H., Terea, H., Abdullah, M. M. S., Trzepieciński, T., & Saidane-Mosbahi, D. (2026). Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71658

Vancouver

Nesrat HS, Aouadi A, Laib I, Laouini SE, Bouafia A, Saoud DH, et al. Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71658

BibTeX
@article{Nesrat2026,
  author = {Nesrat, Hocine Sadam and Aouadi, Abdelatif and Laib, Ibtissam and Laouini, Salah Eddine and Bouafia, Abderrhmane and Saoud, Djamila Hamada and Zidane, Halima and Terea, Hafidha and Abdullah, Mahmood M S and Trzepieciński, Tomasz and Saidane-Mosbahi, Dalila},
  title = {Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano‐Platform With Potent Antioxidant, Anti‐Inflammatory, Antidiabetic, and Anti‐Cholinesterase Activities},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71658}
}
Kostenlos starten →